Health Canada accepts nirsevimab regulatory submission for infant RSV
/CNW/ - Health Canada has accepted a New Drug Submission (NDS) for nirsevimab, the first investigational single-dose long-acting antibody designed for all...
Source: newswire.ca
Danielr Feikin News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Danielr Feikin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Danielr Feikin Today - Breaking & Trending Today